Open access
Sep 2026
Evaluation of the Effect of Cendakimab on the Pharmacokinetics of CYP Probe Drugs in Patients With Eosinophilic Esophagitis
Cendakimab had no clinically meaningful effects on cytochrome P450 enzyme activities and was generally safe and well tolerated with or without probe substrates in adults with active eosinophilic esophagitis.
Pei-Jin Zhang, C. Charriez, Bindu Murthy et al.
· Clinical and Translational S... · 0 citations